Redox-mediated signal transduction by cardiovascular Nox NADPH oxidases

Journal of Molecular and Cellular Cardiology

Volumn 73, Issue , 2014, Pages 70-79

  Brandes, Ralf P ^a   Weissmann, Norbert ^b   Schröder, Katrin ^a  

^a GOETHE UNIVERSITY   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Hydrogen peroxide; NADPH oxidase; Nitric oxide; Oxidative stress; Redox regulation; Thiol

Indexed keywords

APOPTOSIS SIGNAL REGULATING KINASE 1; CALCIUM; HYDROGEN PEROXIDE; HYPOXIA INDUCIBLE FACTOR 1; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 PHOSPHATE; PHOSPHATIDYLINOSITOL 3 PHOSPHATE KINASE PHOSPHOINOSITIDE DEPENDENT KINASE; PROTEIN 14 3 3; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 1B; PROTEIN TYROSINE PHOSPHATASE SHP 2; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 5; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CARDIOVASCULAR SYSTEM; DOWN REGULATION; DRUG TARGETING; ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME METABOLISM; ENZYME RELEASE; EPIGENETICS; GENE EXPRESSION; HUMAN; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; METABOLISM; PHYSIOLOGY;

ANIMALS; CARDIOVASCULAR SYSTEM; HUMANS; NADPH OXIDASE; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84901847598     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.02.006     Document Type: Review

References (141)

1. Forman H.J., Ursini F., Maiorino M. An overview of mechanisms of redox signaling. J Mol Cell Cardiol 2014, 73:2-9. (in this issue).
2. Ray P.D., Huang B.W., Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 2012, 24:981-990.
3. Brewer A.C., Mustafi S.B., Murray T.V., Rajasekaran N.S., Benjamin I.J. Reductive stress linked to small HSPs, G6PD, and Nrf2 pathways in heart disease. Antioxid Redox Signal 2013, 18:1114-1127.
4. Sturza A., Leisegang M.S., Babelova A., Schroder K., Benkhoff S., Loot A.E., et al. Monoamine oxidases are mediators of endothelial dysfunction in the mouse aorta. Hypertension 2013, 62:140-146.
5. Bedard K., Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007, 87:245-313.
6. Hafstad A.D., Nabeebaccus A.A., Shah A.M. Novel aspects of ROS signalling in heart failure. Basic Res Cardiol 2013, 108:359.
7. Lassegue B., San M.A., Griendling K.K. Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ Res 2012, 110:1364-1390.
8. Schramm A., Matusik P., Osmenda G., Guzik T.J. Targeting NADPH oxidases in vascular pharmacology. Vascul Pharmacol 2012, 56:216-231.
9. Brandes R.P., Weissmann N., Schroder K. NADPH oxidases in cardiovascular disease. Free Radic Biol Med 2010, 49:687-706.
10. Patel V.B., Wang Z., Fan D., Zhabyeyev P., Basu R., Das S.K., et al. Loss of p47phox subunit enhances susceptibility to biomechanical stress and heart failure because of dysregulation of cortactin and actin filaments. Circ Res 2013, 112:1542-1556.
11. Richter C., Juan M.H., Will J., Brandes R.P., Kalinke U., Akira S., et al. Ncf1 provides a reactive oxygen species-independent negative feedback regulation of TLR9-induced IL-12p70 in murine dendritic cells. J Immunol 2009, 182:4183-4191.
12. Gardner P.R. Superoxide-driven aconitase FE-S center cycling. Biosci Rep 1997, 17:33-42.
13. Conrad M., Sandin A., Forster H., Seiler A., Frijhoff J., Dagnell M., et al. 12/15-Lipoxygenase-derived lipid peroxides control receptor tyrosine kinase signaling through oxidation of protein tyrosine phosphatases. Proc Natl Acad Sci U S A 2010, 107:15774-15779.
14. Poole L.B., Hall A., Nelson K.J. Overview of peroxiredoxins in oxidant defense and redox regulation. Curr Protoc Toxicol 2011, [Chapter 7:Unit 7.9]. 10.1002/0471140856.tx0709s49.
15. Go Y.M., Jones D.P. Thiol/disulfide redox states in signaling and sensing. Crit Rev Biochem Mol Biol 2013, 48:173-181.
16. Ushio-Fukai M. Compartmentalization of redox signaling through NADPH oxidase-derived ROS. Antioxid Redox Signal 2009, 11:1289-1299.
17. Miller F.J., Filali M., Huss G.J., Stanic B., Chamseddine A., Barna T.J., et al. Cytokine activation of nuclear factor kappa B in vascular smooth muscle cells requires signaling endosomes containing Nox1 and ClC-3. Circ Res 2007, 101:663-671.
18. Rhee S.G., Woo H.A., Kil I.S., Bae S.H. Peroxiredoxin functions as a peroxidase and a regulator and sensor of local peroxides. J Biol Chem 2012, 287:4403-4410.
19. Laurindo F.R., Pescatore L.A., Fernandes D.C. Protein disulfide isomerase in redox cell signaling and homeostasis. Free Radic Biol Med 2012, 52:1954-1969.
20. Schulz E., Wenzel P., Munzel T., Daiber A. Mitochondrial redox signaling: interaction of mitochondrial reactive oxygen species with other sources of oxidative stress. Antioxid Redox Signal 2014, 20:308-324.
21. Corcoran A., Cotter T.G. Redox regulation of protein kinases. FEBS J 2013, 280:1944-1965.
22. Boivin B., Yang M., Tonks N.K. Targeting the reversibly oxidized protein tyrosine phosphatase superfamily. Sci Signal 2010, 3:l2.
23. Seshiah P.N., Weber D.S., Rocic P., Valppu L., Taniyama Y., Griendling K.K. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res 2002, 91:406-413.
24. Touyz R.M., Yao G., Schiffrin E.L. c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2003, 23:981-987.
25. Gianni D., Bohl B., Courtneidge S.A., Bokoch G.M. The involvement of the tyrosine kinase c-Src in the regulation of reactive oxygen species generation mediated by NADPH oxidase-1. Mol Biol Cell 2008, 19:2984-2994.
26. 2+- and phospholipid-independent activation of protein kinase C by selective oxidative modification of the regulatory domain. Proc Natl Acad Sci U S A 1989, 86:6758-6762.
27. Brandes R.P., Kreuzer J. Vascular NADPH oxidases: molecular mechanisms of activation. Cardiovasc Res 2005, 65:16-27.
28. Chignalia A.Z., Schuldt E.Z., Camargo L.L., Montezano A.C., Callera G.E., Laurindo F.R., et al. Testosterone induces vascular smooth muscle cell migration by NADPH oxidase and c-Src-dependent pathways. Hypertension 2012, 59:1263-1271.
29. Xi G., Shen X., Maile L.A., Wai C., Gollahon K., Clemmons D.R. Hyperglycemia enhances IGF-I-stimulated Src activation via increasing Nox4-derived reactive oxygen species in a PKCzeta-dependent manner in vascular smooth muscle cells. Diabetes 2012, 61:104-113.
30. Jagadeesha D.K., Takapoo M., Banfi B., Bhalla R.C., Miller F.J. Nox1 transactivation of epidermal growth factor receptor promotes N-cadherin shedding and smooth muscle cell migration. Cardiovasc Res 2012, 93:406-413.
31. Yoo S.K., Starnes T.W., Deng Q., Huttenlocher A. Lyn is a redox sensor that mediates leukocyte wound attraction in vivo. Nature 2011, 480:109-112.
32. Zhu Q.S., Xia L., Mills G.B., Lowell C.A., Touw I.P., Corey S.J. G-CSF induced reactive oxygen species involves Lyn-PI3-kinase-Akt and contributes to myeloid cell growth. Blood 2006, 107:1847-1856.
33. Lee H.M., Jeon B.H., Won K.J., Lee C.K., Park T.K., Choi W.S., et al. Gene transfer of redox factor-1 inhibits neointimal formation: involvement of platelet-derived growth factor-beta receptor signaling via the inhibition of the reactive oxygen species-mediated Syk pathway. Circ Res 2009, 104:219-227. [5 pp.].
34. Bae Y.S., Lee J.H., Choi S.H., Kim S., Almazan F., Witztum J.L., et al. Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2. Circ Res 2009, 104:210-218. [21 pp.].
35. Loot A.E., Schreiber J.G., Fisslthaler B., Fleming I. Angiotensin II impairs endothelial function via tyrosine phosphorylation of the endothelial nitric oxide synthase. J Exp Med 2009, 206:2889-2896.
36. Yang C.M., Lee I.T., Hsu R.C., Chi P.L., Hsiao L.D. NADPH oxidase/ROS-dependent PYK2 activation is involved in TNF-alpha-induced matrix metalloproteinase-9 expression in rat heart-derived H9c2 cells. Toxicol Appl Pharmacol 2013, 272:431-442.
37. Chen K., Kirber M.T., Xiao H., Yang Y., Keaney J.F. Regulation of ROS signal transduction by NADPH oxidase 4 localization. J Cell Biol 2008, 181:1129-1139.
38. Goldstein B.J., Mahadev K., Wu X. Redox paradox: insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets. Diabetes 2005, 54:311-321.
39. Mahadev K., Zilbering A., Zhu L., Goldstein B.J. Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade. J Biol Chem 2001, 276:21938-21942.
40. Mondol A.S., Tonks N.K., Kamata T. Nox4 redox regulation of PTP1B contributes to the proliferation and migration of glioblastoma cells by modulating tyrosine phosphorylation of coronin-1C. Free Radic Biol Med 2014, 67:285-291.
41. Grinnell K.L., Chichger H., Braza J., Duong H., Harrington E.O. Protection against LPS-induced pulmonary edema through the attenuation of protein tyrosine phosphatase-1B oxidation. Am J Respir Cell Mol Biol 2012, 46:623-632.
42. Sharma P., Chakraborty R., Wang L., Min B., Tremblay M.L., Kawahara T., et al. Redox regulation of interleukin-4 signaling. Immunity 2008, 29:551-564.
43. Schieffer B., Luchtefeld M., Braun S., Hilfiker A., Hilfiker-Kleiner D., Drexler H. Role of NAD(P)H oxidase in angiotensin II-induced JAK/STAT signaling and cytokine induction. Circ Res 2000, 87:1195-1201.
44. Jay D.B., Papaharalambus C.A., Seidel-Rogol B., Dikalova A.E., Lassegue B., Griendling K.K. Nox5 mediates PDGF-induced proliferation in human aortic smooth muscle cells. Free Radic Biol Med 2008, 45:329-335.
45. Tabet F., Schiffrin E.L., Callera G.E., He Y., Yao G., Ostman A., et al. Redox-sensitive signaling by angiotensin II involves oxidative inactivation and blunted phosphorylation of protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells from SHR. Circ Res 2008, 103:149-158.
46. Schroder K., Kohnen A., Aicher A., Liehn E.A., Buchse T., Stein S., et al. NADPH oxidase Nox2 is required for hypoxia-induced mobilization of endothelial progenitor cells. Circ Res 2009, 105:537-544.
47. Chen C.H., Cheng T.H., Lin H., Shih N.L., Chen Y.L., Chen Y.S., et al. Reactive oxygen species generation is involved in epidermal growth factor receptor transactivation through the transient oxidization of Src homology 2-containing tyrosine phosphatase in endothelin-1 signaling pathway in rat cardiac fibroblasts. Mol Pharmacol 2006, 69:1347-1355.
48. Lee J.K., Edderkaoui M., Truong P., Ohno I., Jang K.T., Berti A., et al. NADPH oxidase promotes pancreatic cancer cell survival via inhibiting JAK2 dephosphorylation by tyrosine phosphatases. Gastroenterology 2007, 133:1637-1648.
49. Shinohara M., Adachi Y., Mitsushita J., Kuwabara M., Nagasawa A., Harada S., et al. Reactive oxygen generated by NADPH oxidase 1 (Nox1) contributes to cell invasion by regulating matrix metalloprotease-9 production and cell migration. J Biol Chem 2010, 285:4481-4488.
50. Shinohara M., Shang W.H., Kubodera M., Harada S., Mitsushita J., Kato M., et al. Nox1 redox signaling mediates oncogenic Ras-induced disruption of stress fibers and focal adhesions by down-regulating Rho. J Biol Chem 2007, 282:17640-17648.
51. Aghajanian A., Wittchen E.S., Campbell S.L., Burridge K. Direct activation of RhoA by reactive oxygen species requires a redox-sensitive motif. PLoS One 2009, 4:e8045.
52. Mitchell L., Hobbs G.A., Aghajanian A., Campbell S.L. Redox regulation of Ras and Rho GTPases: mechanism and function. Antioxid Redox Signal 2013, 18:250-258.
53. Adachi T., Pimentel D.R., Heibeck T., Hou X., Lee Y.J., Jiang B., et al. S-glutathiolation of Ras mediates redox-sensitive signaling by angiotensin II in vascular smooth muscle cells. J Biol Chem 2004, 279:29857-29862.
54. Wu R.F., Ma Z., Myers D.P., Terada L.S. HIV-1 Tat activates dual Nox pathways leading to independent activation of ERK and JNK MAP kinases. J Biol Chem 2007, 282:37412-37419.
55. Anilkumar N., Weber R., Zhang M., Brewer A., Shah A.M. Nox4 and nox2 NADPH oxidases mediate distinct cellular redox signaling responses to agonist stimulation. Arterioscler Thromb Vasc Biol 2008, 28:1347-1354.
56. Takac I., Schroder K., Zhang L., Lardy B., Anilkumar N., Lambeth J.D., et al. The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4. J Biol Chem 2011, 286:13304-13313.
57. Acharya S., Peters A.M., Norton A.S., Murdoch G.K., Hill R.A. Change in Nox4 expression is accompanied by changes in myogenic marker expression in differentiating C2C12 myoblasts. Pflugers Arch 2013, 465:1181-1196.
58. Giannoni E., Chiarugi P. Redox circuitries driving Src regulation. Antioxid Redox Signal 2013, [PMID: 23901911].
59. Sedeek M., Gutsol A., Montezano A.C., Burger D., Nguyen Dinh C.A., Kennedy C.R., et al. Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes. Clin Sci (Lond) 2013, 124:191-202.
60. Kim H.S., Ullevig S.L., Zamora D., Lee C.F., Asmis R. Redox regulation of MAPK phosphatase 1 controls monocyte migration and macrophage recruitment. Proc Natl Acad Sci U S A 2012, 109:E2803-E2812.
61. Seth D., Rudolph J. Redox regulation of MAP kinase phosphatase 3. Biochemistry 2006, 45:8476-8487.
62. Yang C.S., Shin D.M., Lee H.M., Son J.W., Lee S.J., Akira S., et al. ASK1-p38 MAPK-p47phox activation is essential for inflammatory responses during tuberculosis via TLR2-ROS signalling. Cell Microbiol 2008, 10:741-754.
63. Viedt C., Soto U., Krieger-Brauer H.I., Fei J., Elsing C., Kubler W., et al. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species. Arterioscler Thromb Vasc Biol 2000, 20:940-948.
64. Brandes R.P., Viedt C., Nguyen K., Beer S., Kreuzer J., Busse R., et al. Thrombin-induced MCP-1 expression involves activation of the p22phox-containing NADPH oxidase in human vascular smooth muscle cells. Thromb Haemost 2001, 85:1104-1110.
65. Schroder K., Helmcke I., Palfi K., Krause K.H., Busse R., Brandes R.P. Nox1 mediates basic fibroblast growth factor-induced migration of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2007, 27:1736-1743.
66. Lee M.Y., San M.A., Mehta P.K., Dikalova A.E., Garrido A.M., Datla S.R., et al. Mechanisms of vascular smooth muscle NADPH oxidase 1 (Nox1) contribution to injury-induced neointimal formation. Arterioscler Thromb Vasc Biol 2009, 29:480-487.
67. Ushio-Fukai M. VEGF signaling through NADPH oxidase-derived ROS. Antioxid Redox Signal 2007, 9:731-739.
68. Schroder K., Schutz S., Schloffel I., Batz S., Takac I., Weissmann N., et al. Hepatocyte growth factor induces a proangiogenic phenotype and mobilizes endothelial progenitor cells by activating Nox2. Antioxid Redox Signal 2011, 15:915-923.
69. Persson C., Savenhed C., Bourdeau A., Tremblay M.L., Markova B., Bohmer F.D., et al. Site-selective regulation of platelet-derived growth factor beta receptor tyrosine phosphorylation by T-cell protein tyrosine phosphatase. Mol Cell Biol 2004, 24:2190-2201.
70. Peng Z., Arendshorst W.J. Activation of phospholipase C gamma 1 protects renal arteriolar VSMCs from H2O2-induced cell death. Kidney Blood Press Res 2008, 31:1-9.
71. Vockel M., Vestweber D. How T cells trigger the dissociation of the endothelial receptor phosphatase VE-PTP from VE-cadherin. Blood 2013, 122:2512-2522.
72. Sandin A., Dagnell M., Gonon A., Pernow J., Stangl V., Aspenstrom P., et al. Hypoxia followed by re-oxygenation induces oxidation of tyrosine phosphatases. Cell Signal 2011, 23:820-826.
73. Grazia L.M., Zanetti A., Corada M., Takahashi T., Balconi G., Breviario F., et al. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148. J Cell Biol 2003, 161:793-804.
74. Chabot C., Spring K., Gratton J.P., Elchebly M., Royal I. New role for the protein tyrosine phosphatase DEP-1 in Akt activation and endothelial cell survival. Mol Cell Biol 2009, 29:241-253.
75. Liu H., Nishitoh H., Ichijo H., Kyriakis J.M. Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor necrosis factor receptor-associated factor 2 requires prior dissociation of the ASK1 inhibitor thioredoxin. Mol Cell Biol 2000, 20:2198-2208.
76. Kimura S., Zhang G.X., Nishiyama A., Shokoji T., Yao L., Fan Y.Y., et al. Role of NAD(P)H oxidase- and mitochondria-derived reactive oxygen species in cardioprotection of ischemic reperfusion injury by angiotensin II. Hypertension 2005, 45:860-866.
77. Kwon J., Lee S.R., Yang K.S., Ahn Y., Kim Y.J., Stadtman E.R., et al. Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors. Proc Natl Acad Sci U S A 2004, 101:16419-16424.
78. Mackey A.M., Sanvicens N., Groeger G., Doonan F., Wallace D., Cotter T.G. Redox survival signalling in retina-derived 661W cells. Cell Death Differ 2008, 15:1291-1303.
79. Handayaningsih A.E., Iguchi G., Fukuoka H., Nishizawa H., Takahashi M., Yamamoto M., et al. Reactive oxygen species play an essential role in IGF-I signaling and IGF-I-induced myocyte hypertrophy in C2C12 myocytes. Endocrinology 2011, 152:912-921.
80. Cui W., Matsuno K., Iwata K., Ibi M., Matsumoto M., Zhang J., et al. NOX1/nicotinamide adenine dinucleotide phosphate, reduced form (NADPH) oxidase promotes proliferation of stellate cells and aggravates liver fibrosis induced by bile duct ligation. Hepatology 2011, 54:949-958.
81. Coant N., Ben M.S., Pedruzzi E., Guichard C., Treton X., Ducroc R., et al. NADPH oxidase 1 modulates WNT and NOTCH1 signaling to control the fate of proliferative progenitor cells in the colon. Mol Cell Biol 2010, 30:2636-2650.
82. Matsuno K., Iwata K., Matsumoto M., Katsuyama M., Cui W., Murata A., et al. NOX1/NADPH oxidase is involved in endotoxin-induced cardiomyocyte apoptosis. Free Radic Biol Med 2012, 53:1718-1728.
83. Kuiper J.W., Sun C., Magalhaes M.A., Glogauer M. Rac regulates PtdInsP(3) signaling and the chemotactic compass through a redox-mediated feedback loop. Blood 2011, 118:6164-6171.
84. Vecchione C., Carnevale D., Di P.A., Gentile M.T., Damato A., Cocozza G., et al. Pressure-induced vascular oxidative stress is mediated through activation of integrin-linked kinase 1/betaPIX/Rac-1 pathway. Hypertension 2009, 54:1028-1034.
85. Kim J.S., Huang T.Y., Bokoch G.M. Reactive oxygen species regulate a slingshot-cofilin activation pathway. Mol Biol Cell 2009, 20:2650-2660.
86. San M.A., Lee M.Y., Williams H.C., Mizuno K., Lassegue B., Griendling K.K. Dual regulation of cofilin activity by LIM kinase and slingshot-1L phosphatase controls platelet-derived growth factor-induced migration of human aortic smooth muscle cells. Circ Res 2008, 102:432-438.
87. Maheswaranathan M., Gole H.K., Fernandez I., Lassegue B., Griendling K.K., San M.A. Platelet-derived growth factor (PDGF) regulates slingshot phosphatase activity via Nox1-dependent auto-dephosphorylation of serine 834 in vascular smooth muscle cells. J Biol Chem 2011, 286:35430-35437.
88. Touyz R.M. Reactive oxygen species as mediators of calcium signaling by angiotensin II: implications in vascular physiology and pathophysiology. Antioxid Redox Signal 2005, 7:1302-1314.
89. Montezano A.C., Burger D., Paravicini T.M., Chignalia A.Z., Yusuf H., Almasri M., et al. Nicotinamide adenine dinucleotide phosphate reduced oxidase 5 (Nox5) regulation by angiotensin II and endothelin-1 is mediated via calcium/calmodulin-dependent, rac-1-independent pathways in human endothelial cells. Circ Res 2010, 106:1363-1373.
90. Carrichon L., Picciocchi A., Debeurme F., Defendi F., Beaumel S., Jesaitis A.J., et al. Characterization of superoxide overproduction by the D-Loop(Nox4)-Nox2 cytochrome b(558) in phagocytes-differential sensitivity to calcium and phosphorylation events. Biochim Biophys Acta 1808, 2011:78-90.
91. Prosser B.L., Ward C.W., Lederer W.J. X-ROS signaling: rapid mechano-chemo transduction in heart. Science 2011, 333:1440-1445.
92. 2+ release channel by NADPH oxidase 4. Proc Natl Acad Sci U S A 2011, 108:16098-16103.
93. Zimmerman M.C., Takapoo M., Jagadeesha D.K., Stanic B., Banfi B., Bhalla R.C., et al. Activation of NADPH oxidase 1 increases intracellular calcium and migration of smooth muscle cells. Hypertension 2011, 58:446-453.
94. Basset O., Deffert C., Foti M., Bedard K., Jaquet V., Ogier-Denis E., et al. NADPH oxidase 1 deficiency alters caveolin phosphorylation and angiotensin II-receptor localization in vascular smooth muscle. Antioxid Redox Signal 2009, 11:2371-2384.
95. Weissmann N., Sydykov A., Kalwa H., Storch U., Fuchs B., Schnitzler M., et al. Activation of TRPC6 channels is essential for lung ischaemia-reperfusion induced oedema in mice. Nat Commun 2012, 3:649.
96. Adachi T., Weisbrod R.M., Pimentel D.R., Ying J., Sharov V.S., Schoneich C., et al. S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. Nat Med 2004, 10:1200-1207.
97. 2+ exchanger contributes to sarcoplasmic reticulum Ca2+ depletion in cardiac myocytes. Free Radic Biol Med 2010, 48:1182-1187.
98. Qin F., Siwik D.A., Lancel S., Zhang J., Kuster G.M., Luptak I., et al. Hydrogen peroxide-mediated SERCA cysteine 674 oxidation contributes to impaired cardiac myocyte relaxation in senescent mouse heart. J Am Heart Assoc 2013, 2:e000184.
99. Tong X., Ying J., Pimentel D.R., Trucillo M., Adachi T., Cohen R.A. High glucose oxidizes SERCA cysteine-674 and prevents inhibition by nitric oxide of smooth muscle cell migration. J Mol Cell Cardiol 2008, 44:361-369.
100. Tong X., Hou X., Jourd'heuil D., Weisbrod R.M., Cohen R.A. Upregulation of Nox4 by TGF{beta}1 oxidizes SERCA and inhibits NO in arterial smooth muscle of the prediabetic Zucker rat. Circ Res 2010, 107:975-983.
101. Evangelista A.M., Thompson M.D., Bolotina V.M., Tong X., Cohen R.A. Nox4- and Nox2-dependent oxidant production is required for VEGF-induced SERCA cysteine-674S-glutathiolation and endothelial cell migration. Free Radic Biol Med 2012, 53:2327-2334.
102. Goettsch C., Babelova A., Trummer O., Erben R.G., Rauner M., Rammelt S., et al. NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis. J Clin Invest 2013, 123:4731-4738.
103. + pump regulation. Circ Res 2009, 105:185-193.
104. + pump and inhibits its activity. J Biol Chem 2010, 285:13712-13720.
105. + pump via NADPH oxidase-dependent β1-subunit glutathionylation: implications for angiotensin II-induced vascular dysfunction. Free Radic Biol Med 2013, 65C:563-572.
106. Luczak E.D., Anderson M.E. CaMKII oxidative activation and the pathogenesis of cardiac disease. J Mol Cell Cardiol 2014, 73:112-116. (in this issue).
107. Erickson J.R., Joiner M.L., Guan X., Kutschke W., Yang J., Oddis C.V., et al. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 2008, 133:462-474.
108. Takac I., Schroder K., Brandes R.P. The Nox family of NADPH oxidases: friend or foe of the vascular system?. Curr Hypertens Rep 2012, 14:70-78.
109. Muzaffar S., Shukla N., Bond M., Sala-Newby G.B., Newby A.C., Angelini G.D., et al. Superoxide from NADPH oxidase upregulates type 5 phosphodiesterase in human vascular smooth muscle cells: inhibition with iloprost and NONOate. Br J Pharmacol 2008, 155:847-856.
110. 2+-calmodulin-dependent phosphodiesterase (PDE1): current perspectives. Cell Signal 2005, 17:789-797.
111. Burgoyne J.R., Oka S., Ale-Agha N., Eaton P. Hydrogen peroxide sensing and signaling by protein kinases in the cardiovascular system. Antioxid Redox Signal 2013, 18:1042-1052.
112. Ray R., Murdoch C.E., Wang M., Santos C.X., Zhang M., Alom-Ruiz S., et al. Endothelial Nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo. Arterioscler Thromb Vasc Biol 2011, 31:1368-1376.
113. Jaulmes A., Sansilvestri-Morel P., Rolland-Valognes G., Bernhardt F., Gaertner R., Lockhart B.P., et al. Nox4 mediates the expression of plasminogen activator inhibitor-1 via p38 MAPK pathway in cultured human endothelial cells. Thromb Res 2009, 124:439-446.
114. Patel D.N., Bailey S.R., Gresham J.K., Schuchman D.B., Shelhamer J.H., Goldstein B.J., et al. TLR4-NOX4-AP-1 signaling mediates lipopolysaccharide-induced CXCR6 expression in human aortic smooth muscle cells. Biochem Biophys Res Commun 2006, 347:1113-1120.
115. Viedt C., Fei J., Krieger-Brauer H.I., Brandes R.P., Teupser D., Kamimura M., et al. Role of p22phox in angiotensin II and platelet-derived growth factor AA induced activator protein 1 activation in vascular smooth muscle cells. J Mol Med (Berl) 2004, 82:31-38.
116. Valente A.J., Yoshida T., Murthy S.N., Sakamuri S.S., Katsuyama M., Clark R.A., et al. Angiotensin II enhances AT1-Nox1 binding and stimulates arterial smooth muscle cell migration and proliferation through AT1, Nox1, and interleukin-18. Am J Physiol Heart Circ Physiol 2012, 303:H282-H296.
117. Murray T.V., Smyrnias I., Shah A.M., Brewer A.C. NADPH oxidase 4 regulates cardiomyocyte differentiation via redox activation of c-Jun protein and the cis-regulation of GATA-4 gene transcription. J Biol Chem 2013, 288:15745-15759.
118. Gorlach A., Diebold I., Schini-Kerth V.B., Berchner-Pfannschmidt U., Roth U., Brandes R.P., et al. Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: role of the p22(phox)-containing NADPH oxidase. Circ Res 2001, 89:47-54.
119. Bonello S., Zahringer C., BelAiba R.S., Djordjevic T., Hess J., Michiels C., et al. Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. Arterioscler Thromb Vasc Biol 2007, 27:755-761.
120. Diebold I., Flugel D., Becht S., BelAiba R.S., Bonello S., Hess J., et al. The hypoxia-inducible factor-2alpha is stabilized by oxidative stress involving NOX4. Antioxid Redox Signal 2010, 13:425-436.
121. Patten D.A., Lafleur V.N., Robitaille G.A., Chan D.A., Giaccia A.J., Richard D.E. Hypoxia-inducible factor-1 activation in nonhypoxic conditions: the essential role of mitochondrial-derived reactive oxygen species. Mol Biol Cell 2010, 21:3247-3257.
122. Zhang M., Brewer A.C., Schroder K., Santos C.X., Grieve D.J., Wang M., et al. NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis. Proc Natl Acad Sci U S A 2010, 107:18121-18126.
123. Calvani M., Comito G., Giannoni E., Chiarugi P. Time-dependent stabilization of hypoxia inducible factor-1alpha by different intracellular sources of reactive oxygen species. PLoS One 2012, 7:e38388.
124. Hitchler M.J., Domann F.E. Redox regulation of the epigenetic landscape in cancer: a role for metabolic reprogramming in remodeling the epigenome. Free Radic Biol Med 2012, 53:2178-2187.
125. Segal B.H., Han W., Bushey J.J., Joo M., Bhatti Z., Feminella J., et al. NADPH oxidase limits innate immune responses in the lungs in mice. PLoS One 2010, 5:e9631.
126. Malec V., Gottschald O.R., Li S., Rose F., Seeger W., Hanze J. HIF-1 alpha signaling is augmented during intermittent hypoxia by induction of the Nrf2 pathway in NOX1-expressing adenocarcinoma A549 cells. Free Radic Biol Med 2010, 48:1626-1635.
127. Brewer A.C., Murray T.V., Arno M., Zhang M., Anilkumar N.P., Mann G.E., et al. Nox4 regulates Nrf2 and glutathione redox in cardiomyocytes in vivo. Free Radic Biol Med 2011, 51:205-215.
128. Schroder K., Zhang M., Benkhoff S., Mieth A., Pliquett R., Kosowski J., et al. Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circ Res 2012, 110:1217-1225.
129. Liu Y., Hernandez-Ochoa E.O., Randall W.R., Schneider M.F. NOX2-dependent ROS is required for HDAC5 nuclear efflux and contributes to HDAC4 nuclear efflux during intense repetitive activity of fast skeletal muscle fibers. Am J Physiol Cell Physiol 2012, 303:C334-C347.
130. Spencer N.Y., Yan Z., Boudreau R.L., Zhang Y., Luo M., Li Q., et al. Control of hepatic nuclear superoxide production by glucose 6-phosphate dehydrogenase and NADPH oxidase-4. J Biol Chem 2011, 286:8977-8987.
131. Matsushima S., Kuroda J., Ago T., Zhai P., Park J.Y., Xie L.H., et al. Increased oxidative stress in the nucleus caused by Nox4 mediates oxidation of HDAC4 and cardiac hypertrophy. Circ Res 2013, 112:651-663.
132. Raz L., Zhang Q.G., Han D., Dong Y., De S.L., Brann D.W. Acetylation of the pro-apoptotic factor, p53 in the hippocampus following cerebral ischemia and modulation by estrogen. PLoS One 2011, 6:e27039.
133. Puca R., Nardinocchi L., Starace G., Rechavi G., Sacchi A., Givol D., et al. Nox1 is involved in p53 deacetylation and suppression of its transcriptional activity and apoptosis. Free Radic Biol Med 2010, 48:1338-1346.
134. Jung S.B., Kim C.S., Kim Y.R., Naqvi A., Yamamori T., Kumar S., et al. Redox factor-1 activates endothelial SIRTUIN1 through reduction of conserved cysteine sulfhydryls in its deacetylase domain. PLoS One 2013, 8:e65415.
135. Varga Z.V., Kupai K., Szucs G., Gaspar R., Paloczi J., Farago N., et al. MicroRNA-25-dependent up-regulation of NADPH oxidase 4 (NOX4) mediates hypercholesterolemia-induced oxidative/nitrative stress and subsequent dysfunction in the heart. J Mol Cell Cardiol 2013, 62:111-121.
136. Jajoo S., Mukherjea D., Kaur T., Sheehan K.E., Sheth S., Borse V., et al. Essential role of NADPH oxidase-dependent reactive oxygen species generation in regulating microRNA-21 expression and function in prostate cancer. Antioxid Redox Signal 2013, 19:1863-1876.
137. Hong J., Li D., Wands J., Souza R., Cao W. Role of NADPH oxidase NOX5-S, NF-kappaB, and DNMT1 in acid-induced p16 hypermethylation in Barrett's cells. Am J Physiol Cell Physiol 2013, 305:C1069-C1079.
138. Xiong F., Xiao D., Zhang L. Norepinephrine causes epigenetic repression of PKCepsilon gene in rodent hearts by activating Nox1-dependent reactive oxygen species production. FASEB J 2012, 26:2753-2763.
139. Matsuno K., Yamada H., Iwata K., Jin D., Katsuyama M., Matsuki M., et al. Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice. Circulation 2005, 112:2677-2685.
140. Yogi A., Mercure C., Touyz J., Callera G.E., Montezano A.C., Aranha A.B., et al. Renal redox-sensitive signaling, but not blood pressure, is attenuated by Nox1 knockout in angiotensin II-dependent chronic hypertension. Hypertension 2008, 51:500-506.
141. Touyz R.M., Mercure C., He Y., Javeshghani D., Yao G., Callera G.E., et al. Angiotensin II-dependent chronic hypertension and cardiac hypertrophy are unaffected by gp91phox-containing NADPH oxidase. Hypertension 2005, 45:530-537.